由于含有Para-Amino化合物的染发剂引起的职业喘
Virginie Doyen1, Jolanta Walusiak-Skorupa2, Marta Wiszniewska2
1Department of Chest Medicine, Centre Hospitalier Universitaire UCL Namur, Catholic University of Louvain, Yvoir, Belgium.
American journal of industrial medicine
|November 19, 2025
概括
含有亚胺基化合物 (PAC) 的氧化染料是发型师职业喘 (OA) 的重要原因. 需要进一步的研究,以了解这种与工作相关的喘背后的免疫机制.
科学领域:
- 职业健康 职业健康 职业健康 职业健康
- 皮肤病学 皮肤病学
- 免疫学 免疫学 免疫学
背景情况:
- 发型漂白剂中的硫酸盐已知是发型师的职业喘 (OA) 的原因.
- 有限的数据存在于毛发产品中其他低分子量化学物质引起的OA.
研究的目的:
- 调查由含有亚胺基化合物 (PAC) 的氧化染发剂引起的职业喘 (OA) 的患病率和临床特征.
主要方法:
- 追溯多中心研究涉及98名患有OA的理发师.
- 用头发产品的积极特异性吸入挑战 (SIC) 用于诊断.
- 九名理发师 (9%) 对含有PAC的染发剂SIC反应呈阳性.
主要成果:
- 八名理发师在使用染发剂的"工作模拟"SIC期间经历了支气管反应.
- 在43%的受试者中观察到增加的非特异性气道过敏反应.
- 没有注意到分数呼出的氧化或唾液中异氨基细胞的显著增加.
结论:
- 含有PAC的氧化染发剂可能会在理发师中大大促进职业喘 (OA).
- 在评估与工作相关的喘发型师时,考虑PAC至关重要.
- 需要进一步研究炎症和免疫机制.
相关概念视频
Physical Properties of Amines
4.1K
Amines with low molecular weight are usually gaseous at room temperature, while those with high molecular weight are liquid or solids in nature. Usually, low molecular weight amines have a rotten fish-like smell. Diamines typically have a pungent smell. For instance, cadaverine and putrescine, depicted in Figure 1, are two molecules responsible for decaying tissue.
4.1K
Local Anesthetics: Adverse Effects
742
While local anesthetics are generally safe and well-tolerated, they can occasionally cause adverse effects that vary in severity. Local anesthetics can induce toxicity at two distinct levels. They can either produce local effects through direct contact with the neural elements or be absorbed into the bloodstream from the injection site, leading to systemic effects.
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
742
Asthma-I: Introduction
3.3K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.3K
Asthma-II: Pathophysiology and Classification
4.0K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.0K
Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
Antiasthma Drugs: Muscarinic Receptor Antagonists
1.6K
Muscarinic receptor antagonists, also known as antimuscarinic agents, are a class of bronchodilators used to treat asthma, although they are more commonly used to treat COPD. They work by inhibiting the action of acetylcholine (ACh), a neurotransmitter, on muscarinic receptors found in the airways.
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
1.6K


